Whoops! … may contain a carcinogen –

July 9, 2020 – Two more pharmaceutical companies have issued a recall for a medication used to control high blood sugar in people with Type 2 diabetes because it may contain a carcinogen.

Lupin Pharmaceuticals Inc. issued the recall for all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 1000 mg because “additional analysis revealed that certain tested batches were above the Acceptable Daily Intake Limit for the impurity N-Nitrosodimethylamine (NDMA),” according to a statement posted by the U.S. Food and Drug Administration.



Subscribe Today! Your best source of current news, information and opinion about the issues that matter to you most. Serving the treatment industry, recovery community and health and wellness professionals.